Company Overview
About Ottobock
Ottobock is a German medical technology company and the world''s market leader in prosthetics, with a dominant position in orthotics, neuro-orthotics, exoskeletons, and mobility solutions including wheelchairs. Founded in 1919 and headquartered in Duderstadt, Germany, Ottobock has over a century of innovation history — including pioneering myoelectric prosthetic arms, microprocessor-controlled knees, and bionically enhanced limb systems. The company serves people with physical disabilities and limb loss globally through a combination of clinical care, device manufacturing, and healthcare professional training.
Business Model & Competitive Advantage
In October 2025, Ottobock completed its Initial Public Offering on the Frankfurt Stock Exchange Prime Standard under the ticker OBCK.F, pricing at €66 per share and raising €808 million with an implied company valuation of approximately €4.2 billion. The IPO was the largest German IPO of 2025. Prior to listing, Näder Holding (the founding family vehicle) controlled 80% of Ottobock and repurchased EQT''s remaining 20% stake for €1.1 billion in March 2024. Ottobock employs approximately 9,300 full-time staff and operates in 45 countries.
Competitive Landscape 2025–2026
Ottobock''s product portfolio spans high-tech bionic prosthetic legs and arms, custom orthotic braces, dynamic orthotics for neurological conditions, powered exoskeletons for rehabilitation, and manual and power wheelchairs. The company is presenting new prosthetic and orthotic innovations at OTWorld 2026 in Leipzig. Ottobock competes with Össur, Fillauer, and other prosthetics and orthotics manufacturers, but its scale, clinical reach, and 100+ year brand heritage create a durable competitive moat.
Key Differentiators
Market Leader
Ottobock is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Similar Brands
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,
Biogen
Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and com
West Pharmaceutical Services
West Pharmaceutical Services, Inc. is the global leader in packaging components and delivery systems for injectable medications, designing and manufacturing the stoppers, closures, caps, and drug deli
Compare Ottobock with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Ottobock? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Ottobock Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ottobock vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →